Elsevier Announces New Journal Partnership for 2008
Elsevier is pleased to announce that in 2008 the leading fatty-acid research journal Prostaglandins, Leukotrienes & Essential Fatty Acids (PLEFA) will become the Official Journal of the International Society for the Study of Fatty Acids and Lipids (ISSFAL).
2008 also marks the journal’s 30th Anniversary. PLEFA was founded in 1978 as Prostaglandins and Medicine by the late David F Horrobin, and published by Churchill Livingstone. PLEFA addresses all aspects of the roles of lipids and their metabolites in cellular, organ and whole-organism function, and places a particular emphasis on human studies. The relevance of this research, including into omega-3 fatty acids, to the development of novel treatments for disease is growing.
Current Editor-in-Chief Mehar S Manku comments, “The affiliation of ISSFAL to PLEFA is an important step in both the journal and society’s growth and maturity. We warmly welcome ISSFAL members to PLEFA. Many ISSFAL members have previous experience of publication in PLEFA and therefore the association between the parties seems a natural one. We will work together to better understand the role of fatty acids and their several important bioactive metabolites in health and disease. Our common aim is to make PLEFA the leading journal in this field.”
In addition, “There is no doubt that in science, communication is crucial. ISSFAL has become the recognised scientific society in the field of lipids in nutrition, and as such needs a recognised medium to facilitate that communication. PLEFA is a key journal in this field, and so a link is logical between the two. ISSFAL is therefore pleased to make PLEFA the Official Journal of the Society. I wish every success for this promising joint venture,” states Michel Lagarde, President of ISSFAL.
In 2008, all members of ISSFAL will have full online access to PLEFA, including its 30-year archive, online via a new site: External link www.PLEFA.com
The role of lipids, including essential fatty acids and their prostaglandin, leukotriene and other derivatives, is now evident in almost all areas of biomedical science. Cell membrane behaviour and cell signalling in all tissues are highly dependent on the lipid constituents of cells. External link Prostaglandins, Leukotrienes & Essential Fatty Acids aims to cover all aspects of the roles of lipids in cellular, organ and whole organism function, and places a particular emphasis on human studies. Papers concerning all medical specialties are published. Much of the material is particularly relevant to the development of novel treatments for disease. PLEFA is Medline indexed, and has an Impact Factor of 2.261 (Journal Citation Reports ® 2007, Published by Thomson Scientific).
External link ISSFAL is an International Scientific Society established in 1991, of more than 500 members from more than 40 countries. ISSFAL members are scientists, medical professionals, educators, administrators, communicators and others with an interest in the health effects of dietary fats, oils and lipids; members include researchers carrying out studies on the health effects of omega-3 and omega-6 fatty acids, conjugated linoleic acids, saturated and monounsaturated fatty acids as well as other lipids. ISSFAL is the foremost International Scientific Society dealing exclusively with the health impact of dietary lipids.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as External link ScienceDirect, External link MD Consult, External link Scopus, bibliographic databases, and online reference works.
External link Elsevier is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of External link Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier’s ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Andrew Miller, PhD
+44 (0) 1865 8438 23
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.